Facebook Pixel Code

Shukra Pharmaceuticals Share Price

NSE
BSE

SHUKRA PHARMACEUTICALS

Smallcap | BSE

Here's the live share price of Shukra Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹39.82 Closed
6.87₹ 2.56
As on Aug 12, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Source: Dion Global

Shukra Pharmaceuticals Price Performance

Today's LowToday's High
₹34.00₹40.26
₹39.82
52 Weeks' Low52 Weeks' High
₹17.06₹65.26
₹39.82
Open Price
₹37.00
Prev. Close
₹37.26
Volume
21,34,540

Source: Dion Global

Shukra Pharmaceuticals Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Shukra Pharmaceuticals
20.3417.5031.51-5.73113.17132.03152.20
Sun Pharmaceutical Industries
-0.720.574.8312.8519.3019.4719.96
Divi's Laboratories
2.3423.2528.6238.0943.3531.8111.72
Torrent Pharmaceuticals
-2.16-1.1711.6419.8134.7835.3827.42
Zydus Lifesciences
8.376.4529.3630.7625.9323.3517.21
Cipla
0.802.4413.129.93-3.895.7710.06
Lupin
-5.08-9.330.832.4716.5127.9318.34
Mankind Pharma
-1.12-3.371.9916.63-0.2610.0711.23
Dr. Reddy's Laboratories
2.13-2.89-5.60-5.93-1.770.994.93
Laurus Labs
-0.0918.2045.0080.69121.5968.5321.04
Aurobindo Pharma
3.207.4411.8443.8357.3724.0715.06
Biocon
0.874.426.6014.2420.7918.982.75
Alkem Laboratories
-3.40-1.88-0.57-6.636.2012.998.48
Glenmark Pharmaceuticals
1.07-1.270.7411.7010.4641.7631.82
Abbott India
1.612.914.775.60-12.876.088.70
Anthem Biosciences
6.3217.489.7024.9018.096.333.75
Gland Pharma
12.9216.8353.5458.3549.2021.50-7.81
Ipca Laboratories
-0.39-3.5116.4119.2927.8825.818.09
GlaxoSmithKline Pharmaceuticals
2.098.397.03-1.751.2022.7710.27
Ajanta Pharma
3.033.4814.6222.6331.2327.0318.78

Source: Dion Global

Over the last one year, Shukra Pharmaceuticals has gained 113.17% compared to peers like Sun Pharmaceutical Industries (19.30%), Divi's Laboratories (43.35%), Torrent Pharmaceuticals (34.78%). From a 5 year perspective, Shukra Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (19.96%) and Divi's Laboratories (11.72%).

Shukra Pharmaceuticals Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Source: Dion Global

Shukra Pharmaceuticals Stock Technicals

Moving Average

DaySMAEMA
535.7436.89
1033.1235.17
2033.0233.79
5031.6832.74
10032.2933.45
20038.4133.48

Source: Dion Global

Shukra Pharmaceuticals Share Holding Pattern

In the latest quarter, Shukra Pharmaceuticals saw a rise in promoter holding to 51.16%, while DII stake unchanged at 0.11%, FII holding unchanged at 0.00%, and public shareholding moved down to 48.74% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Shukra Pharmaceuticals Corporate Actions

Date Time
Announcement
Aug 12, 2026, 08:16 PM IST ISTShukra Pharma. - Quarterly Results June 30, 2026
Aug 12, 2026, 08:10 PM IST ISTShukra Pharma. - Board Meeting Outcome for Quartely Results June 30, 2026
Aug 06, 2026, 11:41 PM IST ISTShukra Pharma. - Update on board meeting
Jul 31, 2026, 12:49 AM IST ISTShukra Pharma. - Board Meeting Intimation for Quarterly Results
Jul 15, 2026, 01:06 AM IST ISTShukra Pharma. - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday, Ju

Source: Dion Global

About Shukra Pharmaceuticals

Shukra Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/03/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1993PLC019079 and registration number is 019079. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 56.71 Cr. and Equity Capital is Rs. 43.79 Cr. for the Year ended 31/03/2026.

Source: Dion Global

Management

  • Mr. Dakshesh Rameshchandra Shah
    Managing Director
  • Mrs. Payal Sujay Mehta
    Executive Director
  • Mr. Dhruvin Shah
    Whole Time Director
  • Mr. Sanskruti Jayeshbhai Patel
    Whole Time Director
  • Mrs. Anar Jayeshbhai Patel
    Whole Time Director
  • Mrs. Shital Shah
    Whole Time Director
  • Mrs. Bhoomiben Patel
    Independent Director
  • Mrs. Sonal Deepalbhai Gandhi
    Independent Director
  • Mr. Sarjeevan Singh Rathore
    Independent Director
  • Mr. Jitendra Somchand Shah
    Independent Director
  • Mrs. Pinki Nirmal Sagar
    Independent Director
  • Mrs. Ritu Kapoor
    Independent Director

FAQs on Shukra Pharmaceuticals Share Price

What is the share price of Shukra Pharmaceuticals?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Shukra Pharmaceuticals is ₹39.82 as on Aug 12, 2026.

What kind of stock is Shukra Pharmaceuticals?

The Shukra Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Shukra Pharmaceuticals?

The market cap of Shukra Pharmaceuticals is ₹1,750.54 Cr as on Aug 12, 2026.

What are today's High and Low prices of Shukra Pharmaceuticals?

Today’s highest and lowest price of Shukra Pharmaceuticals are ₹40.26 and ₹34.00.

What are the 52 Week High and 52 Week Low of Shukra Pharmaceuticals?

The 52-week high/low is the highest and lowest price at which Shukra Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Shukra Pharmaceuticals is ₹65.26 and 52-week low of Shukra Pharmaceuticals is ₹17.06 as on Aug 12, 2026.

How has the Shukra Pharmaceuticals performed historically in terms of returns?

The Shukra Pharmaceuticals has shown returns of 6.87% over the past day, 17.5% for the past month, 31.51% over 3 months, 113.17% over 1 year, 132.03% across 3 years, and 152.2% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Shukra Pharmaceuticals?

P/E ratio of and PB ratio of Shukra Pharmaceuticals are 79.37 and 19.45 on Aug 12, 2026. While the company gives a dividend yield of 0.03 per annum.

Source: Dion Global

Shukra Pharmaceuticals News